Literature DB >> 3017006

HTLV-III antibody testing in three Danish blood banks.

B Orskov Lindhardt, K Ulrich, L Ryder, E Dickmeiss, H Sørensen, J Jørgensen, C Jersild, N Grunnet.   

Abstract

The Organon Teknika Vironostika anti-HTLV-III/LAV test was evaluated in three Danish blood banks. The evaluation comprised in total 3,940 consecutive donors. In all three blood banks the tests were carried out exactly according to the manufacturer's instructions, using a low cut-off value defined as (4N + P)/5, where N and P are means of optical densities of known negative and positive samples. By this method the overall frequency of repeatably positive samples was 0.30%. When tested by Western blot, however, none of these samples were shown to contain specific antibodies against HTLV-III/LAV proteins. When testing different categories of patients, only sera containing HLA antibodies gave rise to false-positive reactions. Finally, important differences in the results were observed regarding sample preparation, single or dual wavelength optical density readings, and the experience of the technical staff.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3017006     DOI: 10.1111/j.1423-0410.1986.tb01987.x

Source DB:  PubMed          Journal:  Vox Sang        ISSN: 0042-9007            Impact factor:   2.144


  5 in total

1.  Lymphocyte transformation response to pokeweed mitogen as a predictive marker for development of AIDS and AIDS related symptoms in homosexual men with HIV antibodies.

Authors:  B Hofmann; B O Lindhardt; J Gerstoft; C S Petersen; P Platz; L P Ryder; N Odum; E Dickmeiss; P B Nielsen; S Ullman
Journal:  Br Med J (Clin Res Ed)       Date:  1987-08-01

2.  Antibodies against the major core protein p24 of human immunodeficiency virus: relation to immunological, clinical and prognostic findings.

Authors:  B O Lindhardt; J Gerstoft; B Hofmann; G Pallesen; L Mathiesen; E Dickmeiss; K Ulrich
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-07       Impact factor: 3.267

3.  Analysis of a highly immunodominant epitope in the human immunodeficiency virus type 1 transmembrane glycoprotein, gp41, defined by a human monoclonal antibody.

Authors:  T H Bugge; B O Lindhardt; L L Hansen; P Kusk; E Hulgaard; K Holmbäck; P J Klasse; J Zeuthen; K Ulrich
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

4.  Thyroid hypofunction related with the progression of human immunodeficiency virus infection.

Authors:  A Olivieri; M Sorcini; P Battisti; C Fazzini; E Gilardi; Y Sun; E Medda; M Grandolfo; G Tossini; S Natili
Journal:  J Endocrinol Invest       Date:  1993-06       Impact factor: 4.256

5.  Serological response in patients with chronic asymptomatic human immunodeficiency virus infection.

Authors:  B O Lindhardt; K Ulrich; P Kusk; B Hofmann
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-06       Impact factor: 3.267

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.